+612 9045 4394
 
CHECKOUT
Cancer Chemotherapy and Biological Response Modifiers : Annual 21 - Giuseppe Giaccone

Cancer Chemotherapy and Biological Response Modifiers

Annual 21

By: Giuseppe Giaccone (Editor), Richard L. Schilsky (Editor), Paul Sondel (Editor)

Hardcover Published: 9th December 2003
ISBN: 9780444514585
Number Of Pages: 916

Share This Book:

Hardcover

RRP $464.99
$321.50
31%
OFF
or 4 easy payments of $80.38 with Learn more
Ships in 10 to 15 business days

Cancer Chemotherapy & Biological Response Modifiers Annual 21 contains an expanded section on Colorectal Cancer, an area that has seen remarkable progress in screening, early detection, prevention and therapy in just the last few years. Annual 21 also includes updates on biology and treatment of common malignancies as well as chapters that summarise recent advances in chemotherapy and immunotherapy for cancer.

Introduction
Thymidylate synthase inhibitorsp. 1
Anthracyclinesp. 29
Tubulin-targeting agentsp. 41
Topoisomerase I interactive agentsp. 69
Topoisomerase II inhibitorsp. 103
Farnesyltransferase inhibitorsp. 127
Cyclin-dependent kinases as targets for cancer therapyp. 145
DNA-binding agentsp. 171
Advances in endocrine therapy for the treatment and prevention of breast cancerp. 211
Monoclonal antibody therapy for breast cancer: Herceptinp. 223
Rituximabp. 235
Mucins in gastrointestinal cancersp. 259
HER-2/neu vaccinesp. 275
Colon cancer antigen and anti-idiotype vaccinesp. 287
Anti-carcinoembryonic antigen immunityp. 299
Cancer gene therapy and immunotherapyp. 327
Recent areas of development for dendritic cell vaccinesp. 339
Mechanisms of tumor evasion from the immune responsep. 351
Plasma cell myeloma and leukemiap. 365
Lymphomasp. 399
Head and neck cancersp. 429
Lung cancerp. 445
Upper gastrointestinal tumorsp. 485
Cancers of the large bowel and hepatobiliary tractp. 509
Neuroendocrine tumors - somatostatin receptor expression and somatostatin analog treatmentp. 535
Genitourinary malignanciesp. 547
Systemic therapy for gynecological neoplasms: ovary, cervix and endometriump. 565
Breast cancerp. 585
Melanoma - new developments in diagnosis and therapyp. 609
Sarcomap. 637
Brain tumorsp. 655
Biology and therapy of malignant solid tumors in childhoodp. 683
Supportive carep. 709
AIDs-associated malignanciesp. 717
Risk assessment and screening for colorectal cancerp. 747
Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer preventionp. 759
Molecular predictors of prognosis and response to therapy in colorectal cancerp. 791
Combined modality therapy for rectal cancerp. 803
New drugs for colorectal cancerp. 817
Liver directed therapies for colorectal cancerp. 831
Abbreviations of drugsp. 845
Abbreviations of chemotherapeutic combinationsp. 849
Biological abbreviationsp. 853
NSC-numbersp. 859
Subject indexp. 861
Table of Contents provided by Blackwell. All Rights Reserved.

ISBN: 9780444514585
ISBN-10: 0444514589
Audience: Professional
Format: Hardcover
Language: English
Number Of Pages: 916
Published: 9th December 2003
Publisher: Elsevier Health Sciences
Country of Publication: GB
Dimensions (cm): 27.3 x 20.1  x 4.1
Weight (kg): 2.26

This product is categorised by